Search research articles
Contact Us
Filters
Showing results (161-170 of 194) with videos related to
Page
of 20
Sort By:
Cancer Treatment Reports
|
August 1, 1986
Phase II study of mitoxantrone in patients with mesothelioma: a National Cancer Institute of Canada Clinical Trials Group Study
E A Eisenhauer, W K Evans, D Raghavan, et al.
The Journal of Urology
|
February 24, 2009
Phase II trial of neoadjuvant nab-paclitaxel in high risk patients with prostate cancer undergoing radical prostatectomy
D R Shepard, R Dreicer, J Garcia, et al.
Archivos Espanoles De Urologia
|
January 1, 1990
Chemotherapy for invasive bladder cancer: facts and fallacies
D Raghavan, B S Pearson, G J Coorey, et al.
Australian and New Zealand Journal of Medicine
|
February 1, 1983
Lorazepam as an adjunct to antiemetic therapy with haloperidol in patients receiving cytotoxic chemotherapy
M L Friedlander, J H Kearsley, K Sims, et al.
Cancer Treatment Reports
|
February 1, 1987
Mitomycin and mitoxantrone in previously treated patients with advanced breast cancer
J F Bishop, D Raghavan, R Woods, et al.
European Journal of Cancer & Clinical Oncology
|
November 1, 1987
Metastatic adenocarcinoma of unknown primary site. A randomized study of two combination chemotherapy regimens
S T Milliken, M H Tattersall, R L Woods, et al.
The Journal of Urology
|
September 1, 1991
Benign prostatic hyperplasia--video image analysis and its relationship to androgen and epidermal growth factor receptor expression
M Frydenberg, T M Foo, A S Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 1997
Translational studies of glutathione in bladder cancer cell lines and human specimens
L Pendyala, S Velagapudi, K Toth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1990
Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group
J A Levi, D Thomson, V Harvey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1997
Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study
S B Saxman, K J Propert, L H Einhorn, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 194) with videos related to
Sort By:
Page
of 20
Cancer Treatment Reports
|
August 1, 1986
Phase II study of mitoxantrone in patients with mesothelioma: a National Cancer Institute of Canada Clinical Trials Group Study
E A Eisenhauer, W K Evans, D Raghavan, et al.
The Journal of Urology
|
February 24, 2009
Phase II trial of neoadjuvant nab-paclitaxel in high risk patients with prostate cancer undergoing radical prostatectomy
D R Shepard, R Dreicer, J Garcia, et al.
Archivos Espanoles De Urologia
|
January 1, 1990
Chemotherapy for invasive bladder cancer: facts and fallacies
D Raghavan, B S Pearson, G J Coorey, et al.
Australian and New Zealand Journal of Medicine
|
February 1, 1983
Lorazepam as an adjunct to antiemetic therapy with haloperidol in patients receiving cytotoxic chemotherapy
M L Friedlander, J H Kearsley, K Sims, et al.
Cancer Treatment Reports
|
February 1, 1987
Mitomycin and mitoxantrone in previously treated patients with advanced breast cancer
J F Bishop, D Raghavan, R Woods, et al.
European Journal of Cancer & Clinical Oncology
|
November 1, 1987
Metastatic adenocarcinoma of unknown primary site. A randomized study of two combination chemotherapy regimens
S T Milliken, M H Tattersall, R L Woods, et al.
The Journal of Urology
|
September 1, 1991
Benign prostatic hyperplasia--video image analysis and its relationship to androgen and epidermal growth factor receptor expression
M Frydenberg, T M Foo, A S Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 1997
Translational studies of glutathione in bladder cancer cell lines and human specimens
L Pendyala, S Velagapudi, K Toth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1990
Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group
J A Levi, D Thomson, V Harvey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1997
Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study
S B Saxman, K J Propert, L H Einhorn, et al.
Page
of 20